244 related articles for article (PubMed ID: 16455122)
1. Treatment and follow-up of the first case of human trypanosomiasis caused by Trypanosoma evansi in India.
Joshi PP; Chaudhari A; Shegokar VR; Powar RM; Dani VS; Somalwar AM; Jannin J; Truc P
Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):989-91. PubMed ID: 16455122
[TBL] [Abstract][Full Text] [Related]
2. Human trypanosomiasis caused by Trypanosoma evansi in India: the first case report.
Joshi PP; Shegokar VR; Powar RM; Herder S; Katti R; Salkar HR; Dani VS; Bhargava A; Jannin J; Truc P
Am J Trop Med Hyg; 2005 Sep; 73(3):491-5. PubMed ID: 16172469
[TBL] [Abstract][Full Text] [Related]
3. Resistance to drug by different isolates Trypanosoma evansi in China.
Zhou J; Shen J; Liao D; Zhou Y; Lin J
Acta Trop; 2004 May; 90(3):271-5. PubMed ID: 15099814
[TBL] [Abstract][Full Text] [Related]
4. A rare case of human trypanosomiasis caused by Trypanosoma evansi.
Powar RM; Shegokar VR; Joshi PP; Dani VS; Tankhiwale NS; Truc P; Jannin J; Bhargava A
Indian J Med Microbiol; 2006 Jan; 24(1):72-4. PubMed ID: 16505565
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Brazilian isolates of Trypanosoma evansi to suramin sodium: test in experimentally infected mice.
Faccio L; Da Silva AS; Gressler LT; Tonin AA; Lazzarotto CR; Miletti LC; Monteiro SG
Exp Parasitol; 2013 Jul; 134(3):309-12. PubMed ID: 23562880
[TBL] [Abstract][Full Text] [Related]
6. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
Witola WH; Inoue N; Ohashi K; Onuma M
Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
[TBL] [Abstract][Full Text] [Related]
7. Short report: Human trypanosomiasis caused by Trypanosoma evansi in a village in India: preliminary serologic survey of the local population.
Shegokar VR; Powar RM; Joshi PP; Bhargava A; Dani VS; Katti R; Zare VR; Khanande VD; Jannin J; Truc P
Am J Trop Med Hyg; 2006 Nov; 75(5):869-70. PubMed ID: 17123979
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma evansi infections in Himalayan black bears (Selenarctos thibetanus).
Muhammad G; Saqib M; Sajid MS; Naureen A
J Zoo Wildl Med; 2007 Mar; 38(1):97-100. PubMed ID: 17469282
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of furazolidone against experimental infections with Trypanosoma evansi in camels and mice in Sudan: comparisons with quinapyramine and suramin.
Ali BH; Hassan T; Malik KH
Rev Elev Med Vet Pays Trop; 1986; 39(2):197-201. PubMed ID: 3589066
[No Abstract] [Full Text] [Related]
10. The effect of the parasite burden on the curative dose in experimental trypanosomiasis.
Walker PJ; Opiyo EA
Trans R Soc Trop Med Hyg; 1973; 67(2):281-2. PubMed ID: 4274036
[No Abstract] [Full Text] [Related]
11. Genetic characterization of Trypanosoma evansi isolated from a patient in India.
Truc P; Gibson W; Herder S
Infect Genet Evol; 2007 Mar; 7(2):305-7. PubMed ID: 16934537
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of human trypanosomiases.
Wéry M; Burke J
J Chemother; 1989 Jul; 1(4 Suppl):962-4. PubMed ID: 16312723
[No Abstract] [Full Text] [Related]
13. Chemotherapy of Trypanosoma venezuelense (T. evansi) II. Activity of metal-free organic trypanocides in mice and in vitro.
Minelli EB; Iudice G; Ercoli N
Ann Trop Med Parasitol; 1981 Aug; 75(4):383-92. PubMed ID: 7305506
[No Abstract] [Full Text] [Related]
14. Drug-resistance in Trypanosoma evansi.
Gill BS
Trop Anim Health Prod; 1971; 3(4):195-8. PubMed ID: 5164595
[No Abstract] [Full Text] [Related]
15. Use of cymelarsan in goats chronically infected with Trypanosoma evansi.
Gutierrez C; Corbera JA; Bayou K; van Gool F
Ann N Y Acad Sci; 2008 Dec; 1149():331-3. PubMed ID: 19120242
[TBL] [Abstract][Full Text] [Related]
16. Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya.
Otsyula M; Kamar K; Mutugi M; Njogu AR
Acta Trop; 1992 Feb; 50(3):271-3. PubMed ID: 1348603
[No Abstract] [Full Text] [Related]
17. Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening.
Gillingwater K; Büscher P; Brun R
Vet Parasitol; 2007 Sep; 148(2):114-21. PubMed ID: 17624671
[TBL] [Abstract][Full Text] [Related]
18. In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model.
Gillingwater K; Kumar A; Anbazhagan M; Boykin DW; Tidwell RR; Brun R
Antimicrob Agents Chemother; 2009 Dec; 53(12):5074-9. PubMed ID: 19786604
[TBL] [Abstract][Full Text] [Related]
19. Study of immunity to Trypanosoma evansi following drug cure of the infection.
Gill BS
Ann Soc Belges Med Trop Parasitol Mycol; 1971; 51(2):215-9. PubMed ID: 4254936
[No Abstract] [Full Text] [Related]
20. Molecular diagnosis and phylogeographic analysis of Trypanosoma evansi in dogs (Canis lupus familiaris) suggest an epidemiological importance of this species in Colombia.
Jaimes-Dueñez J; Triana-Chávez O; Valencia-Hernández A; Sánchez-Arévalo D; Poche-Ceballos A; Ortíz-Álvarez J; Mejía-Jaramillo AM
Prev Vet Med; 2017 Apr; 139(Pt A):82-89. PubMed ID: 28364836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
